Academic literature on the topic 'Cervical cancer recurrence'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cervical cancer recurrence.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cervical cancer recurrence"

1

van den Tillaart, Sabrina A. H. M., Annelies Schoneveld, Inge T. Peters, et al. "Abdominal Scar Recurrences of Cervical Cancer: Incidence and Characteristics: A Case-Control Study." International Journal of Gynecologic Cancer 20, no. 6 (2010): 1031–40. http://dx.doi.org/10.1111/igc.0b013e3181db5153.

Full text
Abstract:
Background:Tumor recurrence in the surgical scar after radical hysterectomy for cervical cancer has been reported, but the incidence is unknown. Facts about patient and tumor characteristics and follow-up are lacking. The objective of this study was to analyze the incidence and characteristics of cervical cancer scar recurrences.Methods:All patients who were surgically treated for cervical cancer in our center between 1984 and 2007 were reviewed for scar recurrences. For each case, 5 random controls were selected. Clinical characteristics were compared between the cases and controls.Results:El
APA, Harvard, Vancouver, ISO, and other styles
2

Gaikwad, Sujata. "The Scenario of Recurrence of Cervical Cancer by Epigenetics." International Journal for Research in Applied Science and Engineering Technology 11, no. 12 (2023): 129–40. http://dx.doi.org/10.22214/ijraset.2023.57250.

Full text
Abstract:
Abstract: Epigenetic changes happen all the time during life, however, some differences are responsible for specific diseases. One such disease is cancer; nevertheless, a cancer recurrence can be exceedingly lethal and hasten the demise process. Epigenetic changes have the power to completely rule out all current modalities of treatment and have a rapid and substantial impact on the recurrence of cancer. Research indicates that recurrences may occur in up to 70% of individuals with stage III to IVB of cervical cancer. Even with extensive therapy, the 5-year overall survival (OS) rate for recur
APA, Harvard, Vancouver, ISO, and other styles
3

Dzhurayev, Mirzhalol Dekhkanovich, Khilola Ubayduldayevna Ortikova, Mehriniso Rakhmonovna Oripova, and Nodir Mahammatkulovich Rakhimov. "Key Priorities For Immunohistochemical Testing In Predicting Cervical Cancer Recurrence." American Journal of Medical Sciences and Pharmaceutical Research 03, no. 06 (2021): 87–93. http://dx.doi.org/10.37547/tajmspr/volume03issue06-14.

Full text
Abstract:
Cervical cancer is an urgent problem due to its high morbidity, its growth tendency in women of reproductive age, and late presentation. As a result of insufficiently effective surgical and/or radiation treatment of the primary tumor, local recurrences occur in 10-40% of treated patients, and distant metastases in 35% of patients [10]. The first place according to the frequency of distant metastasis in RCC patients is occupied by para-aortic lymph nodes (31.2%), the second - lungs (16.1%), the third - bones (12.9%) [9]. Treatment of recurrent and generalized cervical cancer is a complex and un
APA, Harvard, Vancouver, ISO, and other styles
4

Ubaydullayevna, Ortikova Hilola, Esankulova Bustonoy Sobirovna, and Musayev Mexroj Bakhtiyorovich. "PREDICTION AND STUDY OF THE OCCURRENCE OF CERVICAL CANCER RECURRENCE." International Journal of Medical Sciences And Clinical Research 03, no. 04 (2023): 121–24. http://dx.doi.org/10.37547/ijmscr/volume03issue04-19.

Full text
Abstract:
Cervical cancer has been found to have increased morbidity and mortality in women around the world. Despite complex treatment according to stratification, the risk of relapse is observed in up to 40% of patients Purpose of the study: - Improving the result of early diagnosis of recurrence of cervical cancer stump after complex treatment, by determining the value of the immune response by immunohistochemical markers in combination with the results of complex research methods Materials and methods: - The basis of the research work was a retrospective analysis of the results of the examination an
APA, Harvard, Vancouver, ISO, and other styles
5

Mourton, S. M., Y. Sonoda, N. R. Abu-Rustum, B. H. Bochner, R. R. Barakat, and D. S. Chi. "Resection of recurrent cervical cancer after total pelvic exenteration." International Journal of Gynecologic Cancer 17, no. 1 (2007): 137–40. http://dx.doi.org/10.1111/j.1525-1438.2007.00807.x.

Full text
Abstract:
The objective of this study was to describe the management of patients with recurrent cervical cancer after total pelvic exenteration (TPE). We reviewed the records of patients who underwent TPE for recurrent cervical cancer between June 1992 and December 2003 and subsequently developed recurrent disease. Thirty-seven patients underwent TPE during the study period, and 25 (68%) subsequently developed recurrence proven by radiographic and/or biopsy studies. Recurrence sites included pelvic (12), inguinal (5), retroperitoneal (5), hepatic (4), vulva (2), perineum (1), transposed ovary (1), and l
APA, Harvard, Vancouver, ISO, and other styles
6

Atjimakul, Thiti, and Jitti Hanprasertpong. "Clinical Outcomes and Their Prognostic Factors among Cervical Cancer Patients with Bone Recurrence." Obstetrics and Gynecology International 2022 (September 10, 2022): 1–6. http://dx.doi.org/10.1155/2022/3446293.

Full text
Abstract:
Background. Bone recurrence occurs in 0.75%-8% of cervical cancer patients after primary treatment. Only a few previous studies have reported on survival times associated with prognostic factors for bone recurrent cervical cancer. This study aimed to evaluate the oncological outcomes and their predictors among cervical cancer patients with bone recurrence. Methods. The medical records of cervical cancer patients with bone recurrence who received primary treatment at Songklanagarind Hospital from January 2002 to December 2017 were retrospectively reviewed. Prognostic factors were identified usi
APA, Harvard, Vancouver, ISO, and other styles
7

Tazhibayeva, K., A. Sadykova, D. Tasboltaeva, A. Ormanov, and G. Kaldygozova. "Ways to improve the diagnostics and detection of cervical cancer development and recurrence risk." Oncologia i radiologia Kazakhstana 62, no. 4 (2021): 24–27. http://dx.doi.org/10.52532/2663-4864-2021-4-62-24-27.

Full text
Abstract:
Relevance: Cervical cancer is the fourth leading cause of female death and the third most common female cancer worldwide.
 The purpose of the study was to determine risk factors and time to progression and recurrence in patients with cervical cancer after complex treatment (neoadjuvant chemotherapy + radical hysterectomy + combined radiation therapy).
 Materials and methods: This retrospective study involved female patients with stage IB-IIA cervical cancer registered at Shymkent city oncological dispensary in 2011-2021 (n=883). All patients underwent radical hysterectomy with pelvic
APA, Harvard, Vancouver, ISO, and other styles
8

Musacchio, Michael J., Anthony W. Kim, Joseph D. Vijungco, and Richard A. Prinz. "Greater Local Recurrence Occurs with “Berry Picking” than Neck Dissection in Thyroid Cancer." American Surgeon 69, no. 3 (2003): 191–97. http://dx.doi.org/10.1177/000313480306900303.

Full text
Abstract:
Managing cervical lymph node metastases in well-differentiated thyroid cancer with either “berry picking” (BP) or anatomic neck dissection (AND) has not been shown to alter survival. Nevertheless local control of thyroid cancer is important. The purpose of this study is to determine whether the local recurrence rate of well-differentiated thyroid cancer is equivalent with BP versus AND. A retrospective analysis revealed 41 patients with well-differentiated thyroid cancer and cervical node metastases seen by a single surgeon from 1985 to 2002. A total of 83 initial and repeat neck operations we
APA, Harvard, Vancouver, ISO, and other styles
9

Brown, A. K., S. Gillis, C. Deuel, C. Angel, C. Glantz, and B. Dubeshter. "Abnormal cervical cytology: a risk factor for endometrial cancer recurrence." International Journal of Gynecologic Cancer 15, no. 3 (2005): 517–22. http://dx.doi.org/10.1136/ijgc-00009577-200505000-00017.

Full text
Abstract:
The objective of this study was to evaluate the relationship between cervical cytology, histologic type, and risk of endometrial cancer recurrence. We performed a retrospective study of patients undergoing surgery for endometrial carcinoma. Risk factors for recurrence including histology, tumor grade, nodal status, myometrial invasion, peritoneal washings, stage, and cervical cytology were assessed. Abnormal cervical cytology was defined as the presence of any endometrial cells on Pap smear. Papillary serous and clear cell carcinomas were considered high-risk histologies. Univariate and multiv
APA, Harvard, Vancouver, ISO, and other styles
10

Moutardier, V., G. Houvenaeghel, M. Martino, et al. "Surgical resection of locally recurrent cervical cancer: a single institutional 70 patient series." International Journal of Gynecologic Cancer 14, no. 5 (2004): 846–51. http://dx.doi.org/10.1136/ijgc-00009577-200409000-00016.

Full text
Abstract:
Pelvic recurrence of cervical cancer is a life-threatening situation and only local control can provide hope for remission. The aim of this study was to evaluate the role of surgery in the treatment of cervical cancer recurrence. This retrospective study analyzed a series of 70 patients who underwent resection of cervix locoregional recurrence. Thirteen patients had palliative salvage surgery for pelvic complications. Twenty-nine resections were considered as curative. Fifty recurrences required pelvic exenterations. The hospital mortality rate was 9% and the morbidity rate was 44%. Overall 5-
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cervical cancer recurrence"

1

Roman, Jimenez Geoffrey. "Analyse des images de tomographie par émission de positons pour la prédiction de récidive du cancer du col de l'utérus." Thesis, Rennes 1, 2016. http://www.theses.fr/2016REN1S037/document.

Full text
Abstract:
Ces travaux de thèse s'inscrivent dans le contexte de la prédiction de la récidive en radiothérapie du cancer de l'utérus. L'objectif était d'analyser les images de tomographie par émission de positons (TEP) au 18F-fluorodésoxyglucose (18F-FDG) en vue d'en extraire des paramètres quantitatifs statistiquement corrélés aux événements de récidive. Six études ont été réalisées afin de répondre aux différentes problématiques soulevées par l'analyse des images 18F-FDG TEP telles que la présence d'artefact, l'isolation du métabolisme tumoral ou l'évaluation du signal en cours de traitement. Les étude
APA, Harvard, Vancouver, ISO, and other styles
2

Ye, Yao [Verfasser], and Udo [Akademischer Betreuer] Jeschke. "The roles of EP3 signaling in cervical cancer and recurrent miscarriages / Yao Ye ; Betreuer: Udo Jeschke." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2018. http://d-nb.info/1198111666/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Peng, Lin [Verfasser], and Udo [Akademischer Betreuer] Jeschke. "The role of G-protein coupled prostaglandin E2 receptors (EP2 and EP3) in unexplained recurrent miscarriage and cervical cancer / Lin Peng ; Betreuer: Udo Jeschke." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2021. http://d-nb.info/1239049366/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chung, Yu Ling, and 鄭玉伶. "The association between Sexual Behavior and Recurrence of Cervical Cancer: The exploratory study." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/uyqya5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shao-Pei, Cheng, and 程劭佩. "Epidemiological characteristics of Cervical Cancer in Taiwan (I) Incidence and Mortality analyses (2) Recurrence and Survival associated risk factors." Thesis, 2002. http://ndltd.ncl.edu.tw/handle/35341071360561162425.

Full text
Abstract:
碩士<br>國立臺灣大學<br>預防醫學研究所<br>90<br>This study analyzed incidence rates of invasive cervical cancer and carcinoma in sit in Taiwan from 1979-1998. It retrieved data from Cancer Registry of Department of Health and analyzed changing trends in incidence of invasive cervical cancer and incidence of carcioma in situ along with changing patterns of age and histologic type. In addition, this study used data according to death certificate to analyze the trend in incidence of mortality and factors associated with mortality. In order the stratified the cases into different stages in order for survival a
APA, Harvard, Vancouver, ISO, and other styles
6

Liu, chih-chwen, and 劉致淳. "Identification of prognostic factors for cervical cancer recurrences." Thesis, 1997. http://ndltd.ncl.edu.tw/handle/84435624635696974703.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Parsons, Samantha E. "Risk of recurrent disease in women with cervical intraepithelial neoplasia grades 2 and 3." Thesis, 2017. https://hdl.handle.net/2144/26927.

Full text
Abstract:
BACKGROUND: Cervical cancer has historically been a major cause of mortality for women worldwide. Over the last 50 years, thanks to advances in screening technologies and the implementation of standardized management algorithms, the incidence of cervical cancer in the United States has been declining. LITERATURE REVIEW: In the most recent set of algorithms, the 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors, the authors conclude that there is high-level evidence to support extended screening intervals for women who are
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Cervical cancer recurrence"

1

Negari, Shelly Ben-Harush, and Jessica A. Kahn. Human Papillomavirus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0009.

Full text
Abstract:
Human papillomavirus (HPV) is a ubiquitous, single-stranded DNA virus that is commonly sexually transmitted and an important cause of cervical cancer. Manifestations of infection in the perinatal and childhood periods are recurrent respiratory papillomatosis (RRP) and anogenital warts (AGWs). Children with respiratory papillomatosis most commonly develop papillomas in the larynx, but papillomas may develop in any location along the respiratory tract. Although RRP is rare, it is the most common benign neoplasm of the larynx among children and the second-most-frequent cause of childhood hoarsene
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Cervical cancer recurrence"

1

Montalvo-Esquivel, Gonzalo, Milagros C. Pérez-Quintanilla, Angel Herrera-Gómez, Francisco Javier Alcalá-Prieto, Flavia Morales-Vásquez, and Horacio Noé López Basave. "Surgical Treatment for Advanced or Recurrent Disease in Cervical Cancer." In Cervical Cancer. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zarkavelis, George, Alexandra Papadaki, Aristides Kefas, Ioannis Zerdes, Konstantina Tatsi, and Stergios Boussios. "Management of Recurrent Uterine Cervical Cancer." In Uterine Cervical Cancer. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-02701-8_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Filippini, Daria Maria, and Christophe Le Tourneau. "Therapeutic Potential of Antibody-Drug Conjugates in Head and Neck Cancers." In Critical Issues in Head and Neck Oncology. Springer Nature Switzerland, 2025. https://doi.org/10.1007/978-3-031-84539-0_21.

Full text
Abstract:
Abstract Recurrent/metastatic head and neck cancers remain incurable diseases despite the development of molecularly targeted therapies and immunotherapies. The antibody-drug conjugates (ADCs) are emerging as a novel therapeutic class which integrate the precision of monoclonal antibodies with a cytotoxic drug, referred to as the payload, through a chemical linker, with the aim of selectively delivering this highly toxic payload directly to the cancer cells and, thereby, enhancing the therapeutic index. Various ADCs have been explored and validated across various solid malignancies: the first
APA, Harvard, Vancouver, ISO, and other styles
4

Singh, Kavita, and Bindiya Gupta. "Incompletely Treated and Recurrent Cervical Cancer." In Case-Based Gynecological Oncology. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-36179-1_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mabuchi, Seiji, Mahiru Kawano, Ryoko Takahashi, and Hiromasa Kuroda. "Management of Metastatic and Recurrent Cervical Cancer." In Handbook of Gynecology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-17002-2_5-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nishio, Shin. "Chemotherapy for Advanced and Recurrent Cervical Cancer." In Comprehensive Gynecology and Obstetrics. Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-99-9396-3_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mabuchi, Seiji, Mahiru Kawano, Ryoko Takahashi, and Hiromasa Kuroda. "Management of Metastatic and Recurrent Cervical Cancer." In Handbook of Gynecology. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-17798-4_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kanao, Hiroyuki, and Nobuhiro Takeshima. "Laparoscopic Pelvic Exenteration for Recurrent Cervical Cancer." In Comprehensive Gynecology and Obstetrics. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-1519-0_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Keys, Henry M. "Recurrent Cervical Cancer with Positive Para-aortic Nodes." In Practical Approaches to Cancer Invasion and Metastases. Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-84885-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mabuchi, Seiji, Mahiru Kawano, Ryoko Takahashi, and Hiromasa Kuroda. "Management of Metastatic, Recurrent, and Unusual Cervical Cancer." In Handbook of Gynecology. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-14881-1_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cervical cancer recurrence"

1

Geeitha, S., S. Ananth, P. Renuka, R. Mekala, K. Anitha, and R. Sowmya. "Detecting Gene Sequence of Recurrence Cervical Cancer Interpolating Biomedical Sensors." In 2024 8th International Conference on Computational System and Information Technology for Sustainable Solutions (CSITSS). IEEE, 2024. https://doi.org/10.1109/csitss64042.2024.10816947.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sathyavedu, Prathap, and B. Narendra Kumar Rao. "Improving Cervical Cancer Recurrence Prediction Through Multi-Source Data Integration and Advanced Deep Learning Approaches." In 2025 3rd IEEE International Conference on Industrial Electronics: Developments & Applications (ICIDeA). IEEE, 2025. https://doi.org/10.1109/icidea64800.2025.10963213.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Geeitha, S., P. Renuka, C. Kavitha, S. Umamaheswari, R. Dharani, and K. Gurunathan. "Impact of Hyper Homocysteinemia on Endothelial Dysfunction and Cervical Cancer Recurrence Using Machine Learning Techniques." In 2024 9th International Conference on Communication and Electronics Systems (ICCES). IEEE, 2024. https://doi.org/10.1109/icces63552.2024.10860207.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Geeitha, S., P. Renuka, R. Sowmya, K. Sinduja, C. Kavitha, and S. Umamaheswari. "Feed Forward Neural Network based Prediction of Gene Expression Changes for Immune Responses in Recurrence Cervical Cancer." In 2025 International Conference on Electronics and Renewable Systems (ICEARS). IEEE, 2025. https://doi.org/10.1109/icears64219.2025.10940993.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Geeitha, S., P. Renuka, K. Poongothai, S. Ananth, K. Sinduja, and K. R. Sangeetha. "Disease-Free Survival Prediction in Recurrent Cervical Cancer using Naive Bayes Machine Learning Algorithm." In 2024 5th International Conference on Smart Electronics and Communication (ICOSEC). IEEE, 2024. http://dx.doi.org/10.1109/icosec61587.2024.10722641.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zhang, Lei, Pei He, Chi-Chang Chang, and Wen-Chien Ting. "Grammatical Evolution for Predicting Cervical Cancer Recurrence Risk." In 2023 13th International Conference on Information Technology in Medicine and Education (ITME). IEEE, 2023. http://dx.doi.org/10.1109/itme60234.2023.00173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shukla, H., K. Batra, R. Sekhon, S. Giri, and S. Rawal. "Over view of clinical presentation, management and outcome of cervical cancer: A tertiary cancer centre experience." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685265.

Full text
Abstract:
Objectives: (a) To understand the profile of cervical cancer patients attending our hospital from January 2011 till January 2015. (b) To audit the type of care given to the patients with respect to their stage at presentation. (c) To compare the outcomes of open v/s robotic radical hysterectomy done for cervical cancer. Methods: We prospectively analyzed all cases of cervical cancer from January 2011 to January 2015 presenting at our institute. Data was retrieved from patient’s records and institute’s tumor registry. We compared all patients undergoing open v/s robotic RH. All the data were an
APA, Harvard, Vancouver, ISO, and other styles
8

Sousa, M., G. Cintra, M. Vieira, R. Reis, M. Santos, and CE Andrade. "210 Recurrence after radical hysterectomy in early cervical cancer patients." In IGCS Annual 2019 Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-igcs.210.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, C., B. Lester, L. Huang, S. Sun, and JJ Ko. "132 Survival outcomes in cervical cancer: what factors affect recurrence?" In ESGO 2021 Congress. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-esgo.11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Van Lonkhuijzen, L., L. Dostalek, J. Jarkovsky, et al. "942 Survival after recurrence in early-stage cervical cancer patients." In ESGO 2021 Congress. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-esgo.78.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cervical cancer recurrence"

1

Huang, Kecheng, Xiaoxiong Wu, and Zhilan Chen. Early non-response to neoadjuvant chemotherapy will increase the recurrence of cervical cancer: a system review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.2.0107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Liang, Liju, ZiXuan Yang, MingYuan Zhang, and Hao Guan. The efficacy and safety of Cadonilimab in patients with recurrent/metastatic cervical cancer: a single-arm meta-analysis and systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. https://doi.org/10.37766/inplasy2024.12.0059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Huang, Da, Qionghua He, Lingyun Zhai, et al. Efficacy and safety of Apatinib for the treatment of advanced or recurrent cervical cancer: A single-arm meta-analysis among Chinese patients. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.7.0049.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!